SNF 472

Drug Profile

SNF 472

Alternative Names: Hexasodium phytate; SNF-472

Latest Information Update: 14 Aug 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Laboratoris Sanifit
  • Class Antineoplastics; Calcium regulators; Small molecules; Sugar alcohols
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Calciphylaxis
  • New Molecular Entity No

Highest Development Phases

  • Phase II Calciphylaxis; Cardiovascular disorders

Most Recent Events

  • 07 Aug 2018 Sanifit plans a pivotal phase III trial in Calciphylaxis (calcific uraemic arteriolopathy), in the forth quarter of 2018
  • 06 Aug 2018 Sanifit completes enrolment in the phase IIb CaLIPSO trial for Cardiovascular disorders (linked to calcification in haemodialysis patients) in United Kingdom, Spain and USA
  • 25 May 2018 Interim efficacy and adverse events data from a phase II trial in Calciphylaxis released by Sanifit
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top